Details for New Drug Application (NDA): 021952
✉ Email this page to a colleague
NDA 021952 describes CLARITIN, which is a drug marketed by Bayer Healthcare Llc and is included in eight NDAs. It is available from six suppliers. Additional details are available on the CLARITIN profile page.
The generic ingredient in CLARITIN is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
The generic ingredient in CLARITIN is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 021952
| Tradename: | CLARITIN |
| Applicant: | Bayer Healthcare Llc |
| Ingredient: | loratadine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021952
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Jun 16, 2008 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
